MedPath

a clinical trial to study the effects of two drugs fentanyl and dexmedetomidine added to local anaesthetic ropivacaine in post-operative renal stone disease patients

Completed
Conditions
Calculus of kidney,
Registration Number
CTRI/2018/06/014619
Lead Sponsor
sumit soni
Brief Summary

this study is a randomised double blind, comparing analgesic efficasy of dexmedetomidine and fentanyl used as an adjuvant to ropivacaine in peritubal tract block in percutaneous nephrolithotomy that will be conducted in a tertiary care hospital in north india. the primary outcome measure will be VAS score and DVAS score  in the two groups and total rescue analgesic requirement within 48 hrs in post-operative period.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

adult , ASA grade 1 and ASA grade 2.

Exclusion Criteria

patients requiring supracostal puncture or more than one puncture, patients having excessive intraoperative bleeding, stone size more than 3 cm.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
VAS score and DVAS scoreVAS score and DVAS score assessed at 0 hrs, every hour for next 2 hours, every 2 hour for next 4 hours, and every 6 hour till 48 hours
Secondary Outcome Measures
NameTimeMethod
total rescue analgesic requirement48 hrs

Trial Locations

Locations (1)

pgimer

🇮🇳

Chandigarh, CHANDIGARH, India

pgimer
🇮🇳Chandigarh, CHANDIGARH, India
sumit soni
Principal investigator
7837937589
drssoni19@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.